GLMD•benzinga•
Raymond James Maintains Outperform on Galmed Pharmaceuticals, Lowers Price Target to $5
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 3, 2022 by benzinga